Yangzhi Zhao

Changchun, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 21 publications

Glofitamab for the treatment of relapsed/refractory hairy cell leukemia: a case report.

Glofitamab for the treatment of relapsed/refractory hairy cell leukemia: a case report.

Journal: Leukemia & lymphoma

Published: July 06, 2026

Obinutuzumab versus rituximab-based chemotherapy in high-tumor burden indolent B-cell lymphoma: a real-world comparative study.

Obinutuzumab versus rituximab-based chemotherapy in high-tumor burden indolent B-cell lymphoma: a real-world comparative study.

Journal: Frontiers in immunology

Published: April 16, 2026

Correction: LncRNAs in tumor metabolic reprogramming and tumor microenvironment remodeling.

Correction: LncRNAs in tumor metabolic reprogramming and tumor microenvironment remodeling.

Journal: Frontiers in immunology

Published: January 30, 2026

Polyethylene glycol-conjugated recombinant human granulocyte colony-stimulating factor (PEG-rhG-CSF) primary prophylaxis significantly reduces the duration of neutropenia in non-Hodgkin's lymphoma patients treated with chemotherapy: a randomised trial (NCT05834751).

Polyethylene glycol-conjugated recombinant human granulocyte colony-stimulating factor (PEG-rhG-CSF) primary prophylaxis significantly reduces the duration of neutropenia in non-Hodgkin's lymphoma patients treated with chemotherapy: a randomised trial (NCT05834751).

Journal: Translational cancer research

Published: November 24, 2025

Efficacy and Safety Profile of a Rituximab, Methotrexate, and Thiotepa-Based Regimen in Newly Diagnosed Primary CNS Lymphoma.

Efficacy and Safety Profile of a Rituximab, Methotrexate, and Thiotepa-Based Regimen in Newly Diagnosed Primary CNS Lymphoma.

Journal: International journal of cancer

Published: October 27, 2025

Autoimmune disease-associated lymphomas: research progress and review.

Autoimmune disease-associated lymphomas: research progress and review.

Journal: Frontiers in immunology

Published: October 06, 2025

Chidamide: Exploration of maintenance therapy for patients with DLBCL with HBV infection.

Chidamide: Exploration of maintenance therapy for patients with DLBCL with HBV infection.

Journal: iScience

Published: November 22, 2024

LncRNAs in tumor metabolic reprogramming and tumor microenvironment remodeling.

LncRNAs in tumor metabolic reprogramming and tumor microenvironment remodeling.

Journal: Frontiers in immunology

Published: July 19, 2024

Analysis of hepatitis B virus infection in 1424 patients with different pathological types of lymphoma (2018-2022): A real-world, retrospective study.

Analysis of hepatitis B virus infection in 1424 patients with different pathological types of lymphoma (2018-2022): A real-world, retrospective study.

Journal: Cancer medicine

Published: February 02, 2024

A retrospective study on the efficacy of pegfilgrastim-filgrastim combination regimen in the mobilization for autologous stem cell transplantation in lymphoma patients.

A retrospective study on the efficacy of pegfilgrastim-filgrastim combination regimen in the mobilization for autologous stem cell transplantation in lymphoma patients.

Journal: The American journal of the medical sciences

Published: June 10, 2023

Radiotherapy for extensive-stage small-cell lung cancer in the immunotherapy era.

Radiotherapy for extensive-stage small-cell lung cancer in the immunotherapy era.

Journal: Frontiers in immunology

Published: December 30, 2022

Improving the prognostic ability of PET/CT SUVmax to identify follicular lymphoma with early treatment failure.

Improving the prognostic ability of PET/CT SUVmax to identify follicular lymphoma with early treatment failure.

Journal: American journal of cancer research

Published: June 06, 2022

Showing 1-12 of 21

Last Updated: 09/26/2026